Novartis Ag (NVS) Prepaid Assets (2009 - 2026)
Novartis Ag's (NVS) quarterly Prepaid Assets came in at $3.6 billion in Q2 2026, up 3.79% year-over-year from $3.5 billion in Q2 2025, and down 4.14% quarter-over-quarter from $3.7 billion in Q1 2026.
Analysis
Novartis Ag (NVS) Prepaid Assets (2009 - 2026) Analysis & Trends
Novartis Ag has disclosed Prepaid Assets across 18 years of filings, most recently posting $3.6 billion for Q2 2026.
- In Q2 2026, Prepaid Assets rose 3.79% year-over-year to $3.6 billion; the TTM figure through Jun 2026 stood at $3.6 billion (up 3.79% YoY), while the FY2025 annual figure was $3.5 billion, up 16.54% from the prior year.
- Prepaid Assets came in at $3.6 billion for Q2 2026 at Novartis Ag, down from $3.7 billion in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $3.7 billion in Q1 2026 to a low of $5.0 million in Q1 2022.
- Average Prepaid Assets over 5 years is $2.8 billion, with a median of $2.9 billion recorded in 2023.
- Year-over-year, Prepaid Assets plunged 99.81% in 2022 and jumped 55600.0% in 2023.
- Over 5 years, Prepaid Assets stood at $2.5 billion in 2022, then grew by 5.5% to $2.6 billion in 2023, then increased by 13.85% to $3.0 billion in 2024, then gained by 16.54% to $3.5 billion in 2025, then gained by 3.7% to $3.6 billion in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $3.6 billion in Q2 2026, $3.7 billion in Q1 2026, and $3.5 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.59 Bn |
| Mar 31, 2026 | 3.74 Bn |
| Dec 31, 2025 | 3.46 Bn |
| Sep 30, 2025 | 3.04 Bn |
| Jun 30, 2025 | 3.46 Bn |
| Mar 31, 2025 | 3.36 Bn |
| Dec 31, 2024 | 2.97 Bn |
| Sep 30, 2024 | 3.16 Bn |
| Jun 30, 2024 | 3.03 Bn |
| Mar 31, 2024 | 2.76 Bn |
| Dec 31, 2023 | 2.61 Bn |
| Sep 30, 2023 | 2.78 Bn |
| Jun 30, 2023 | 2.83 Bn |
| Mar 31, 2023 | 2.79 Bn |
| Dec 31, 2022 | 2.47 Bn |
| Sep 30, 2022 | 2.39 Bn |
| Jun 30, 2022 | 2.59 Bn |
| Mar 31, 2022 | 5.00 Mn |
| Dec 31, 2021 | 2.44 Bn |
| Sep 30, 2021 | 2.57 Bn |